D
Immunome, Inc. IMNM
$8.49 $0.030.36% NASDAQ
Recommendation
Prev Close
$8.46
Volume
527,133
Avg Vol (90D)
1,111,392
Market Cap
$736.12M
Dividend & Yield
--
52-Week Range
$5.15 - $16.81
P/E (TTM)
--
EPS (TTM)
-$3.19
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Immunome, Inc. (NASDAQ:IMNM) Shares Bought by Woodline Partners LP
5/23/2025 - Ticker Report
Immunome (NASDAQ:IMNM) Upgraded to Hold at Wall Street Zen
5/23/2025 - Ticker Report
Immunome to Present at Upcoming Investor Conferences
5/22/2025 - Business Wire
Point72 Asset Management L.P. Raises Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)
5/22/2025 - MarketBeat
Immunome (IMNM, $8.56) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
Immunome (IMNM, $8.56) entered Uptrend as Momentum indicator ascends above 0 level on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
Point72 Asset Management L.P. Raises Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)
5/20/2025 - Ticker Report
Cubist Systematic Strategies LLC Invests $902,000 in Immunome, Inc. (NASDAQ:IMNM)
5/17/2025 - MarketBeat
Immunome (NASDAQ:IMNM) Shares Gap Up on Better-Than-Expected Earnings
5/15/2025 - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) is Redmile Group LLC's 7th Largest Position
5/15/2025 - Ticker Report
Immunome (NASDAQ:IMNM) Releases Earnings Results, Beats Expectations By $0.14 EPS
5/14/2025 - MarketBeat
Immunome (IMNM, $7.91) Stochastic Oscillator left the oversold zone on May 13, 2025
5/14/2025 - Tickeron - Stocks
All You Need to Know About Immunome (IMNM) Rating Upgrade to Buy
5/13/2025 - Zacks Investment Research
Immunome (IMNM) Receives a Buy from Lake Street
5/13/2025 - TipRanks Financial Blog
Granahan Investment Management LLC Takes $3.34 Million Position in Immunome, Inc. (NASDAQ:IMNM)
5/13/2025 - MarketBeat
Immunome (IMNM) Receives a Buy from TD Cowen
5/12/2025 - TipRanks Financial Blog
Immunome GAAP EPS of -$0.52 beats by $0.14, revenue of $2.93M beats by $2.47M
5/12/2025 - SeekingAlpha.com: All News
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates
5/12/2025 - Zacks Investment Research
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates
5/12/2025 - Zacks Investment Research
Immunome (IMNM) Financial Update and Clinical Progress in Q1 2025 IMNM Stock News
5/12/2025 - GuruFocus
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update
5/12/2025 - GuruFocus
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update IMNM Stock News
5/12/2025 - GuruFocus
Immunome Inc (IMNM) Q1 2025 Earnings: EPS Loss of $0.52 Beats Estimate, Revenue Soars to $2. ...
5/12/2025 - GuruFocus
Immunome Expands Share Reserve in Inducement Plan
5/12/2025 - TipRanks Financial Blog
Immunome reports Q1 EPS (52c), consensus (57c)
5/12/2025 - The Fly
Income Statement
Total Revenue (TTM)
$10.94M
EBITDA (TTM)
-$175.73M
EBIT (TTM)
-$177.75M
Net Income (TTM)
-$205.11M
Balance Sheet
Total Assets (Q)
$342.69M
Total Debt (Q)
$4.77M
Total Liabilities (Q)
$35.57M
Book Value Per Share (Q)
$3.53
Cash Flow
Cash from Operations (TTM)
-$152.68M
Cash from Investing (TTM)
-$42.74M
Cash from Financing (TTM)
$183.31M
Net Change in Cash (TTM)
-$12.11M
Filings
Filing Date
Monday, May 12, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
0.90
7-Day Total Return
6.52%
30-Day Total Return
36.94%
60-Day Total Return
-4.50%
90-Day Total Return
-9.49%
Year to Date Total Return
-19.37%
1-Year Total Return
-40.80%
2-Year Total Return
49.21%
3-Year Total Return
156.50%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $5.15
52-week High
Jul 29, 2024 - $16.81
Valuation
Market Cap
$736.12M - Small Cap
Enterprise Value
$423.57M
Price/Sales (TTM)
61.44
Price/Book (Q)
2.40
Dividends and Shares
Shares Outstanding
79.41M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
immunome.com
Phone Number
425 939 7410
Address
18702 North Creek Parkway
Bothell, WA 98011
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company’s clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3... more
NASDAQ 05/23/2025 4:00PM Eastern Quotes delayed